229 related articles for article (PubMed ID: 29936317)
1. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
[TBL] [Abstract][Full Text] [Related]
2. The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
Chen CH; Joshi AU; Mochly-Rosen D
Acta Neurol Taiwan; 2016 Dec; 25(4)(4):111-123. PubMed ID: 28382610
[TBL] [Abstract][Full Text] [Related]
3. Impact of mitochondrial aldehyde dehydrogenase 2 on cognitive impairment in the AD model mouse.
Yang Y; Chen W; Wang X; Ge W
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):837-847. PubMed ID: 33954430
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
Grünblatt E; Riederer P
J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase-2 as a therapeutic target.
Kimura M; Yokoyama A; Higuchi S
Expert Opin Ther Targets; 2019 Nov; 23(11):955-966. PubMed ID: 31697578
[No Abstract] [Full Text] [Related]
7. Mitochondrial aldehyde dehydrogenase 2 protects gastric mucosa cells against DNA damage caused by oxidative stress.
Duan Y; Gao Y; Zhang J; Chen Y; Jiang Y; Ji J; Zhang J; Chen X; Yang Q; Su L; Zhang J; Liu B; Zhu Z; Wang L; Yu Y
Free Radic Biol Med; 2016 Apr; 93():165-76. PubMed ID: 26855420
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2).
Stachowicz A; Olszanecki R; Suski M; Głombik K; Basta-Kaim A; Adamek D; Korbut R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218653
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.
D'Souza Y; Elharram A; Soon-Shiong R; Andrew RD; Bennett BM
Mol Brain; 2015 Apr; 8():27. PubMed ID: 25910195
[TBL] [Abstract][Full Text] [Related]
11. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.
Ohta S; Ohsawa I
J Alzheimers Dis; 2006 Jul; 9(2):155-66. PubMed ID: 16873963
[TBL] [Abstract][Full Text] [Related]
13. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
[TBL] [Abstract][Full Text] [Related]
14. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
[TBL] [Abstract][Full Text] [Related]
15. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
16. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart.
Endo J; Sano M; Katayama T; Hishiki T; Shinmura K; Morizane S; Matsuhashi T; Katsumata Y; Zhang Y; Ito H; Nagahata Y; Marchitti S; Nishimaki K; Wolf AM; Nakanishi H; Hattori F; Vasiliou V; Adachi T; Ohsawa I; Taguchi R; Hirabayashi Y; Ohta S; Suematsu M; Ogawa S; Fukuda K
Circ Res; 2009 Nov; 105(11):1118-27. PubMed ID: 19815821
[TBL] [Abstract][Full Text] [Related]
17. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases.
Srivastava S; Haigis MC
Curr Pharm Des; 2011; 17(31):3418-33. PubMed ID: 21902666
[TBL] [Abstract][Full Text] [Related]
18. ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties.
Nannelli G; Terzuoli E; Giorgio V; Donnini S; Lupetti P; Giachetti A; Bernardi P; Ziche M
Oxid Med Cell Longev; 2018; 2018():9765027. PubMed ID: 30538807
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 Activity.
Mali VR; Pan G; Deshpande M; Thandavarayan RA; Xu J; Yang XP; Palaniyandi SS
PLoS One; 2016; 11(10):e0163158. PubMed ID: 27736868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
